Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

Executive Recruitment Roundup – September 2014

Authored by Karl Simpson Genocea Biosciences, a clinical-stage biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Kenneth Bate has joined the company’s board of directors.  He currently is chairman of the board of Cubist Pharmaceuticals, Inc., and … Continue reading

Posted in Executive Appointments, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

Christoph Westphal launches Flex Pharma in Boston Cluster

Authored by James Sheppard The biotech entrepreneur Christoph Westphal has raised $40m in funding for his new biotech startup Flex Pharma. Flex pharma will be based in Boston and pursue new treatments for muscle cramps. Dr Westphal has tapped the … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , | Leave a comment

AM-Pharma raises 12.2m Euros

Authored by James Sheppard The Dutch biotech company AM-Pharma announced that it had raised 12.2m Euros in a financing round. AM-Pharma is a biopharmaceutical company that focuses on the development of recap (recombinant human Alkaline Phosphate) for inflammatory conditions. The … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , | Leave a comment

Oslo Cancer Cluster: Innovation, Funding and the Future

Authored by Karl Simpson Recently appointed to the role of General Manager of the Oslo Cancer Cluster, Ketil Widerberg has a clear vision and grand plans for the Oslo cluster. In part, this future lies in the significant global interest among … Continue reading

Posted in Executive Appointments, M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , | Leave a comment

Oslo Cancer Clusters Biotech Ambition: The Strategic Vision

Authored by Karl Simpson Oslo, Norway is not everyone’s immediate response when asked for their view of an emerging biotech cluster with international prominence. Norway, a country with rich resources and an economy which has been benefiting from the considerable … Continue reading

Posted in Executive Appointments, M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , | Leave a comment

Merck announces collaboration with Advaxis

Authored by James Sheppard The global pharmaceutical giant Merck & Co announced it had partnered with the New Jersey based biotech company Advaxis. The collaboration will see the pair test experimental immuno-oncology drug in combination with a high-profile immunotherapy drug … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment

J&J announces acquisition of Swiss biotech Covagen

Authored by James Sheppard Johnson & Johnson (J&J) has announced it has acquired the BioValley Switzerland based biotech Covagen for an undisclosed amount. Covagen is developing novel anti-inflammatory drugs for psoriasis. Covagen is currently developing its ‘FynomAb’ platform which resulted … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , | Leave a comment

Durata Therapeutics Names New Board Directors

Authored by James Sheppard The Chicago based biotech company Durata Therapeutics has announced the addition of two new board appointments to help lead the company’s development. Durata has appointed Ms Wendy Yarno who was most recently EVP & Chief Marketing … Continue reading

Posted in Executive Appointments, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , | Leave a comment

Tokai Pharmaceuticals appoints Daniel Dransfield as VP Head of Translational Medicine

Authored by James Sheppard The Boston biotech cluster based biopharma company, Tokai Pharmaceuticals, announced that it has appointed Daniel T. Dransfield Ph.D. as Vice President, Head of Translational Medicine. Dr. Dransfield was formerly the VP Discovery & Translational Medicine at … Continue reading

Posted in Executive Appointments, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , | Leave a comment

Roche announces acquisition of InterMune

Authored by James Sheppard The global pharmaceutical company Roche has announced it has purchased the California based, biotech, InterMune, for $8.3bn. The deal will give Roche access to a potential blockbuster drug for idiopathic pulmonary fibrosis. Roche will pay $74 … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap